
Family history creates genetic susceptibility, but lifestyle determines whether that risk becomes reality. Advanced lipid testing reveals cardiovascular risk markers that standard cholesterol tests miss, showing whether your numbers are creeping toward your father's trajectory.
ApoB (Apolipoprotein B) measures the number of atherogenic (plaque-forming) particles in your blood. Standard cholesterol tests measure the amount of cholesterol inside particles, but ApoB counts the particles themselves. One particle can carry varying amounts of cholesterol, so particle count is more predictive of cardiovascular risk than cholesterol content.
When ApoB rises, it reveals you have more plaque-forming particles circulating. Each particle can penetrate artery walls and contribute to plaque buildup. Meanwhile, triglycerides climb and HDL drops, creating an atherogenic pattern. LDL cholesterol might look only mildly elevated, but particle count tells the real story. Combined with elevated CRP (inflammation) and homocysteine (vascular damage marker), the pattern shows cardiovascular risk is building silently.
Key insight: Your father's heart attack at 52 isn't your destiny, but standard cholesterol testing won't reveal your true risk. ApoB and particle counts are more predictive. You can have acceptable LDL but dangerously high ApoB.
Bottom line: Cardiovascular risk reveals how lipid particle count, inflammation, and metabolic health create plaque-building potential. At Lucis, we measure LDL, HDL, triglycerides, ApoB, CRP, and homocysteine. Not just whether your cholesterol is high, but whether your particle pattern and inflammation are creating silent cardiovascular risk.